NasdaqGS - Nasdaq Real Time Price USD

Accolade, Inc. (ACCD)

Compare
3.9590 +0.0990 (+2.56%)
As of 1:59 PM EDT. Market Open.
Loading Chart for ACCD
DELL
  • Previous Close 3.8600
  • Open 3.9200
  • Bid 3.9400 x 500
  • Ask 3.9700 x 200
  • Day's Range 3.8800 - 4.0094
  • 52 Week Range 3.3500 - 15.3600
  • Volume 464,324
  • Avg. Volume 1,527,714
  • Market Cap (intraday) 316.753M
  • Beta (5Y Monthly) 2.00
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1600
  • Earnings Date Oct 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.89

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

www.accolade.com

2,400

Full Time Employees

February 29

Fiscal Year Ends

Recent News: ACCD

View More

Performance Overview: ACCD

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACCD
67.04%
S&P 500
20.47%

1-Year Return

ACCD
62.11%
S&P 500
34.46%

3-Year Return

ACCD
90.81%
S&P 500
28.97%

5-Year Return

ACCD
619.82%
S&P 500
84.42%

Compare To: ACCD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACCD

View More

Valuation Measures

Annual
As of 9/26/2024
  • Market Cap

    308.03M

  • Enterprise Value

    317.99M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.68

  • Price/Book (mrq)

    0.71

  • Enterprise Value/Revenue

    0.74

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -20.62%

  • Return on Assets (ttm)

    -7.89%

  • Return on Equity (ttm)

    -20.01%

  • Revenue (ttm)

    431.53M

  • Net Income Avi to Common (ttm)

    -88.99M

  • Diluted EPS (ttm)

    -1.1600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    230.64M

  • Total Debt/Equity (mrq)

    55.28%

  • Levered Free Cash Flow (ttm)

    20.41M

Research Analysis: ACCD

View More

Company Insights: ACCD

Research Reports: ACCD

View More

People Also Watch